Lysophosphatidic Acid Receptors 1 and 2 Play Roles in Regulation of Vascular Injury Responses but Not Blood Pressure
- 12 September 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 103 (6), 662-670
- https://doi.org/10.1161/circresaha.108.180778
Abstract
Phenotypic modulation of vascular smooth muscle cells (SMCs) is essential for the development of intimal hyperplasia. Lysophosphatidic acid (LPA) is a serum component that can promote phenotypic modulation of cultured SMCs, but an endogenous role for this bioactive lipid as a regulator of SMC function in vivo has not been established. Ligation injury of the carotid artery in mice increased levels in the vessel of both autotaxin, the lysophospholipase D enzyme responsible for generation of extracellular LPA, and 2 LPA responsive G protein–coupled receptors 1 (LPA1) and 2 (LPA2). LPA1−/−2−/− mice were partially protected from the development of injury-induced neointimal hyperplasia, whereas LPA1−/− mice developed larger neointimal lesions after injury. Growth in serum, LPA-induced extracellular signal-regulated protein kinase activation, and migration to LPA and serum were all attenuated in SMCs isolated from LPA1−/−2−/− mice. In contrast, LPA1−/− SMCs exhibited enhanced migration resulting from an upregulation of LPA3. However, despite their involvement in intimal hyperplasia, neither LPA1 nor LPA2 was required for dedifferentiation of SMCs following vascular injury or dedifferentiation of isolated SMCs in response to LPA or serum in vitro. Similarly, neither LPA1 nor LPA2 was required for LPA to elicit a transient increase in blood pressure following intravenous administration of LPA to mice. These results identify a role for LPA1 and LPA2 in regulating SMC migratory responses in the context of vascular injury but suggest that additional LPA receptor subtypes are required for other LPA-mediated effects in the vasculature.Keywords
This publication has 34 references indexed in Scilit:
- Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 2007
- CX 3 CR1 Deficiency Confers Protection From Intimal Hyperplasia After Arterial InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during DevelopmentMolecular and Cellular Biology, 2006
- Emerging medicinal roles for lysophospholipid signalingTrends in Molecular Medicine, 2006
- A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonistBioorganic & Medicinal Chemistry Letters, 2004
- Improved Analysis of the Vascular Response to Arterial Ligation Using a Multivariate ApproachThe American Journal of Pathology, 2004
- Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in BloodJournal of Biological Chemistry, 2002
- Lysophosphatidic Acid Stimulates p21-Activated Kinase in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2002
- Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986